T. Rowe Price Associates
ACHC icon

T. Rowe Price Associates’s Acadia Healthcare ACHC Stock Holding History

T. Rowe Price Associates’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
83,065
+8,158
+11% +$148K ﹤0.01% 1833
2025
Q4 		$1.06M Buy
74,907
+696
+0.9% +$13.2K ﹤0.01% 2060
2025
Q3 		$1.84M Buy
74,211
+5,218
+8% +$116K ﹤0.01% 1767
2025
Q2 		$1.57M Buy
68,993
+1,232
+2% +$29.2K ﹤0.01% 1761
2025
Q1 		$2.06M Buy
67,761
+4,939
+8% +$188K ﹤0.01% 1600
2024
Q4 		$2.49M Buy
62,822
+5,256
+9% +$237K ﹤0.01% 1553
2024
Q3 		$3.65M Buy
57,566
+748
+1% +$54K ﹤0.01% 1397
2024
Q2 		$3.84M Sell
56,818
-76,275
-57% -$5.33M ﹤0.01% 1301
2024
Q1 		$10.5M Buy
133,093
+2,584
+2% +$211K ﹤0.01% 1096
2023
Q4 		$10.1M Buy
130,509
+4,574
+4% +$339K ﹤0.01% 1090
2023
Q3 		$8.86M Sell
125,935
-217,082
-63% -$16.2M ﹤0.01% 1089
2023
Q2 		$27.3M Sell
343,017
-6,953
-2% -$502K ﹤0.01% 853
2023
Q1 		$25.3M Sell
349,970
-151,635
-30% -$11.8M ﹤0.01% 853
2022
Q4 		$41.3M Buy
501,605
+114,505
+30% +$9.44M 0.01% 712
2022
Q3 		$30.3M Sell
387,100
-10,063,402
-96% -$804M 0.01% 784
2022
Q2 		$707M Sell
10,450,502
-148,251
-1% -$10.3M 0.09% 229
2022
Q1 		$695M Sell
10,598,753
-90,206
-0.8% -$5.24M 0.07% 272
2021
Q4 		$649M Buy
10,688,959
+5,146
+0% +$307K 0.06% 302
2021
Q3 		$681M Sell
10,683,813
-6,647
-0.1% -$420K 0.06% 296
2021
Q2 		$671M Sell
10,690,460
-92,041
-0.9% -$5.77M 0.06% 294
2021
Q1 		$616M Buy
10,782,501
+450,307
+4% +$24.4M 0.06% 301
2020
Q4 		$519M Sell
10,332,194
-61,452
-0.6% -$2.45M 0.05% 320
2020
Q3 		$306M Sell
10,393,646
-590,787
-5% -$17.2M 0.04% 391
2020
Q2 		$276M Sell
10,984,433
-2,091,936
-16% -$52.2M 0.03% 403
2020
Q1 		$240M Sell
13,076,369
-686,832
-5% -$19.7M 0.04% 368
2019
Q4 		$457M Buy
13,763,201
+468,555
+4% +$14.7M 0.06% 319
2019
Q3 		$413M Buy
13,294,646
+346,053
+3% +$10.5M 0.06% 314
2019
Q2 		$453M Sell
12,948,593
-649,625
-5% -$21M 0.06% 297
2019
Q1 		$399M Buy
13,598,218
+531,818
+4% +$15.1M 0.06% 305
2018
Q4 		$336M Sell
13,066,400
-603,122
-4% -$20.9M 0.06% 304
2018
Q3 		$481M Buy
13,669,522
+129,356
+1% +$5.15M 0.07% 277
2018
Q2 		$554M Buy
13,540,166
+493,143
+4% +$19.9M 0.08% 234
2018
Q1 		$511M Buy
13,047,023
+2,083,336
+19% +$76.4M 0.08% 248
2017
Q4 		$358M Sell
10,963,687
-79,838
-0.7% -$2.77M 0.06% 331
2017
Q3 		$527M Sell
11,043,525
-74,817
-0.7% -$3.65M 0.09% 241
2017
Q2 		$549M Sell
11,118,342
-801,986
-7% -$35.5M 0.1% 228
2017
Q1 		$520M Sell
11,920,328
-40,396
-0.3% -$1.64M 0.1% 235
2016
Q4 		$396M Buy
11,960,724
+1,002,575
+9% +$38.9M 0.08% 277
2016
Q3 		$543M Buy
10,958,149
+1,103,621
+11% +$57.5M 0.11% 212
2016
Q2 		$546M Buy
9,854,528
+186,596
+2% +$10.9M 0.12% 207
2016
Q1 		$533M Buy
9,667,932
+5,207,875
+117% +$297M 0.11% 206
2015
Q4 		$279M Buy
4,460,057
+288,374
+7% +$18.8M 0.06% 323
2015
Q3 		$276M Buy
4,171,683
+1,298,500
+45% +$99.9M 0.06% 333
2015
Q2 		$225M Buy
2,873,183
+16,200
+0.6% +$1.17M 0.05% 416
2015
Q1 		$205M Buy
2,856,983
+7,740
+0.3% +$496K 0.04% 438
2014
Q4 		$174M Buy
2,849,243
+14,573
+0.5% +$848K 0.04% 467
2014
Q3 		$137M Sell
2,834,670
-8,100
-0.3% -$396K 0.03% 514
2014
Q2 		$129M Buy
2,842,770
+689,220
+32% +$30.3M 0.03% 558
2014
Q1 		$97.2M Sell
2,153,550
-385,010
-15% -$19M 0.02% 641
2013
Q4 		$120M Sell
2,538,560
-126,290
-5% -$5.49M 0.03% 562
2013
Q3 		$105M Sell
2,664,850
-575,100
-18% -$21.3M 0.03% 577
2013
Q2 		$107M Buy
+3,239,950
New +$105M 0.03% 552

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates's ACHC Position: Q1 2026 in Review

T. Rowe Price Associates increased its Acadia Healthcare (ACHC) stake by 11% in Q1 2026, buying an estimated $148K and bringing the position to 83,065 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

T. Rowe Price Associates first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $707M in Q2 2022. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • T. Rowe Price Associates held 83,065 shares of Acadia Healthcare worth $1.94M as of Q1 2026.
  • T. Rowe Price Associates bought 8,158 Acadia Healthcare shares in Q1 2026, an estimated $148K.
  • Acadia Healthcare made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1833 holding.
  • T. Rowe Price Associates first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Acadia Healthcare position peaked at $707M in Q2 2022.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.